| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 10, 2026 | Claret Capital Secures €575M for European Tech, Life Sciences Growth | Claret Capital Partners has finalized its €575 million Fund IV. This significant growth debt fund targets Europe's burgeoning technology and life sciences sectors. It provides flexible, non-dilutive capital. The firm exceeded its €500 milli... |
| Sep 7, 2026 | Claret Capital Partners Raises €575M for European Growth | Claret Capital Partners Closes €575M Fund IV
London-based Claret Capital Partners has raised €575 million through Fund IV and an affiliated discretionary mandate. This surpassed its original €500 million fundraising target. The firm complet... |
| Jul 16, 2026 | Новый модный тренд — вкладывать деньги не в дизайнеров, а в технологии переработки | Американо-канадский производитель спортивной одежды Lululemon принял участие в раунде серии, А французского стартапа Syntetica, который привлек $30 млн на развитие технологии переработки нейлона. Компания разработала способ перерабатывать с... |
| May 26, 2026 | Game-changing accelerator which has helped life science start-ups raise £120m welcomes new cohort | Six exciting early-stage ventures secure coveted spots on Babraham Research Campus’ Accelerate@Babraham pre-seed company support programme.
Cambridge, UK, 26th May 2026: Babraham Research Campus is delighted to announce the 2026 Accelerate@... |
| Sep 5, 2024 | Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule | STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major diseases, today announc... |
| Feb 5, 2024 | Early-stage UK VC Episode 1 closes $95M third fund | Early stage European venture capital (VC) firm Episode 1 has closed its third fund at £76 million ($95 million), as the London-based investor turns to in-house “data-driven deal sourcing tools” to find the next big thing.
Founded in 2013, E... |
| Jan 8, 2024 | BIA reaches 600 member companies, announces new board and leadership restructure | BIA reaches 600 member companies, announces new board and leadership restructure
Mon, Jan 08, 2024 16:00 CET Report this content
London, UK – 8 January 2024: The UK’s innovative trade association for life science and biotech companies, BioI... |
| Nov 14, 2023 | bioProcessUK to celebrate biotech’s shining stars | bioProcessUK to celebrate biotech’s shining stars
Tue, Nov 14, 2023 12:23 CET Report this content
London, United Kingdom, 14/11/2023 - The BioIndustry Association (BIA) will honour two distinguished individuals for their exceptional contrib... |
| Nov 9, 2023 | UK biotech fundraising picks up with best quarterly total since 2021 | UK biotech fundraising picks up with best quarterly total since 2021
Thu, Nov 09, 2023 10:00 CET Report this content
London, United Kingdom, 09/11/2023 - The UK biotech sector secured a substantial total of £563 million in venture capital a... |
| Nov 6, 2023 | Rare disease companies call for UK leadership in supporting access to new treatments | Rare disease companies call for UK leadership in supporting access to new treatments
Mon, Nov 06, 2023 12:01 CET Report this content
London, United Kingdom, 06/11/2023 - A group of companies developing innovative new medicines for rare dise... |
| Oct 18, 2023 | BIA’s report: UK TechBio driving AI revolution in drug discovery and patient care | BIA’s report: UK TechBio driving AI revolution in drug discovery and patient care
Wed, Oct 18, 2023 09:00 CET Report this content
AI, gene editing, engineering biology, and investor interest drive growth in UK bioeconomy.
London, UK, 18 Oct... |
| Oct 10, 2023 | UK-based AstronauTx raises GBP 48 million in Series A | London, United Kingdom-based AstronauTx, a biotech company developing novel treatments for Alzheimer’s disease and other neurodegenerative disorders, raised GBP 48 million (USD 61 million) in Series A financing. The round took place on Octo... |
| Jul 18, 2023 | SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech' | SK Biopharmaceuticals CEO Donghoon Lee maps out its medium to long-term strategy at a press conference
SK Biopharmaceuticals mobilizes its cutting-edge modality platforms of radiopharmaceutical therapy (RPT), targeted protein degradation (T... |
| Jun 5, 2023 | BIA calls on government to support an attractive UK commercial environment for medicines | BIA calls on government to support an attractive UK commercial environment for medicines
Mon, Jun 05, 2023 14:52 CET Report this content
The UK BioIndustry Association (BIA) has today published a report calling for the next Voluntary Pricin... |
| May 12, 2023 | Redx's discovery of Pirtobrutinib recognised with unveiling of commemorative plaque | Redx's discovery of Pirtobrutinib recognised with unveiling of commemorative plaque
Fri, May 12, 2023 12:50 CET Report this content
Redx, the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, ... |
| Apr 5, 2023 | BIA calls on NICE to refresh evidence informing how rare disease medicines are evaluated and paid for | BIA calls on NICE to refresh evidence informing how rare disease medicines are evaluated and paid for
Wed, Apr 05, 2023 11:02 CET Report this content
The UK BioIndustry Association (BIA) has today published research suggesting the UK’s medi... |
| Mar 27, 2023 | BIA launched first of its kind Diversity and Inclusion report for UK biotech and life sciences | BIA launched first of its kind Diversity and Inclusion report for UK biotech and life sciences
Mon, Mar 27, 2023 11:39 CET Report this content
The importance of building a thriving, diverse workplace is a widely recognised priority across a... |
| Jan 26, 2023 | Taking stock - what 2023's policy and finance environment means for biotech | Taking stock - what 2023's policy and finance environment means for biotech
15:30 - 18:45
Pinsent Masons - 30 Crown Place, Earl Street, London, EC2A 4ES
Networking
Ahead of the BIA Gala Dinner, this event will provide key insight and additi... |
| Apr 26, 2022 | CIC Fund II blog from Andrew Williamson | CIC Fund II
BIA blog | By Andrew Williamson
On 25 April 2022 we announced that Cambridge Innovation Capital (CIC) has raised £225m ($300 million) for our oversubscribed second fund, Fund II.
CIC was founded to improve the success rate of bu... |
| Mar 15, 2022 | Cytiva opens doors at Cardiff site as part of $1.5B global expansion | In a September interview with Endpoints News, Cytiva CMO Conor McKechnie said that the company was focusing on in-region, for-region manufacturing as the biopharma world felt the impact of supply woes that affected the entire world.
However... |
| Jan 31, 2022 | Led by Nanopore and Exscientia, UK startups snag half of Europe's biotech VC funding in record-setting 2021 | U.K. biotech and medtech startups reeled in a record 4.5 billion pounds, or $6.05 billion, through venture capital and public financing in 2021, according to the BioIndustry Association and Clarivate.
Nearly $3.4 billion of that heap was vi... |
| Sep 1, 2021 | The U.K. Genomics Startups Changing The Future Of Healthcare Forever | Genomics: the future of healthcare getty |
| Aug 16, 2021 | Life sciences sector alert to evolving skills challenge | ‘We stand on the cusp of an era of cures, in which new technologies make previously terminal diseases treatable or curable’: so states the UK ‘Life Sciences Vision’, which outlines a 10-year strategy for the sector.
The vision, unveiled las... |
| Jul 30, 2021 | Genomics nation: A benchmark of the size and strengths of the UK genomics sector | Genomics nation
A benchmark of the size and strengths of the UK genomics sector
The BIA together with the Wellcome Sanger Institute and the Medicines Discovery Catapult has launched a new report Genomics Nation, showcasing the strength, bre... |
| Feb 2, 2021 | 2020 report cards continue rolling in, with analysts detailing record-breaking fundraising for the UK | The success of the biotech industry in 2020 continues to move into sharper focus with the release of a new report detailing the UK sector’s record-breaking year.
British biotechs collectively pulled in their highest fundra... |
| Oct 12, 2020 | UK biotech secures record £1bn investment in third quarter | The UK biotech industry has enjoyed a boom during the pandemic raising a record £1bn in the third quarter alone. |
| Jun 16, 2020 | Covid-19 roundup: An old, cheap steroid proves to be a major boon to coronavirus patients; BARDA puts $85M behind Regeneron antibody effort | Researchers today spotlighted data from a clinical study offering the first hard evidence that a treatment can save the lives of patients suffering from Covid-19.
The old generic dexamethasone was tied to a one-third red... |
| Jan 22, 2020 | Brexit fears, Woodford woes overshadowed UK biotech and cut 2019 financing by almost half | The venture tide might have subsided, the IPO window may be closing and certain listed biotechs may be having a tough time amid Neil Woodford’s well-publicized demised, but there’s still plenty to celebrate in the UK BioIndus... |
| Mar 25, 2019 | Despite Brexit anxiety, VC investment in UK biotech surges by more than $60M | Of the venture capital raised, the majority – 105 million pounds ($138.4 million) – was Series B, while Series A rounds comprised 35 million pounds ($46.1 million). Additional funding came in the form of 3 million ($4 million) in seed finan... |
| Feb 22, 2019 | Pfizer spinout woos Otsuka vet Raymond Sanchez to lead CNS pipeline work; Joe Anderson returns to Arix helm | Raymond Sanchez
→ Four months after plopping itself down in the center of the neurosciences field with a pipeline from Pfizer and $350 million in launch cash from Bain Capital, Cerevel Therapeutics has recruited a seasoned... |
| Jan 29, 2019 | Melanie Lee, a life in life sciences | Melanie Lee, Chief Executive Officer, LifeArc
Last night I was truly humbled to receive the BioIndustry Association (BIA) Lifetime Achievement Award. I’d like to thank Steve Bates, Jane Osbourne and the BIA for this acknowledgement. I ca... |
| Jan 28, 2019 | Unfazed by Brexit blues, UK biotech trade group celebrates boisterous year of venture dollars with record £1.1B total | A record year of venture investing has floated UK’s biotech boat, with the money flow in 2018 gushing over the £1 billion mark for the first time.
A total of £1.1 billion was raised thanks to a boom in late-stage financings, acc... |
| Nov 30, 2018 | FSD Pharma scoops GW Pharma exec to guide cannabinoid development; Zealand Pharma is looking for a new CEO | → Just a month after GW Pharmaceuticals launched its pioneering cannabis-derived drug in the US, its head of marketing has jumped to lead FSD Pharma, a Canadian biotech that wants to follow GW’s footsteps. Rupert Haynes wil... |
| Sep 28, 2018 | U.K. VC funding hits new high after bumper quarter | The British biotech sector enjoyed a big third quarter for VC financing. With more than £460 million ($600 million) in VC cash flowing into the bank accounts of U.K. biotechs, the sector has now raised 30% more money from public and private... |
| Sep 28, 2018 | U.K. VC funding hits new high after bumper quarter | The British biotech sector enjoyed a big third quarter for VC financing. With more than £460 million ($600 million) in VC cash flowing into the bank accounts of U.K. biotechs, the sector has now raised 30% more money from public and private... |
| Jun 14, 2018 | U.K. creates £2.5B investment program to help startups grow | The U.K. has set up a £2.5 billion ($3.6 billion) patient capital program. The fund is part of an initiative to help British biotechs grow into standalone midsized businesses, rather than sell up at the first sign of a takeover bid from ove... |
| Jun 14, 2018 | U.K. creates £2.5B investment program to help startups grow | The U.K. has set up a £2.5 billion ($3.6 billion) patient capital program. The fund is part of an initiative to help British biotechs grow into standalone midsized businesses, rather than sell up at the first sign of a takeover bid from ove... |
| Jun 12, 2017 | Shock U.K. election result creates uncertainty for biotech
W h i t e p a p e r
Weighing the Costs: | The British biopharma industry is facing further uncertainty after last week’s general election left the country without a clear ruling party. Early polls suggested Theresa May’s Conservatives would win by a landslide, empowering them to im... |
| Jun 12, 2017 | Shock U.K. election result creates uncertainty for biotech | The British biopharma industry is facing further uncertainty after last week’s general election left the country without a clear ruling party. Early polls suggested Theresa May’s Conservatives would win by a landslide, empowering them to im... |
| May 24, 2017 | Funding uncertainty could dent U.K.'s role as Euro biotech hub, says BIA | The U.K. has been closing the gap on the leading life sciences sectors in Boston and the San Francisco Bay area, but uncertainty caused by Brexit could undermine those efforts, said the national industry body.
A report published today by th... |
| May 24, 2017 | Funding uncertainty could dent U.K.'s role as Euro biotech hub, says BIA | The U.K. has been closing the gap on the leading life sciences sectors in Boston and the San Francisco Bay area, but uncertainty caused by Brexit could undermine those efforts, said the national industry body.
Sponsored by Agilent Technolog... |
| Oct 14, 2016 | BIA calls on U.K. to do more for life sciences as Brexit looms | As the British government looks to set out its economic plan for the coming months, biotech trade group the BIA has added what it sees as key policies that need to be strengthened as the country, and business, prepares for Brexit.
As the co... |
| Jun 27, 2016 | UK life sciences industry grapples with new questions from Brexit spanning funding, regulatory landscape | Eleanor Biggs, Cardiovascular & Respiratory Therapy Monitors, at Ipsos Healthcare said in a blog at PharmExec.com that the industry employs 700,000 people in Europe, contributes around 10% of the UK’s gross domestic product and generate... |
| Jun 24, 2016 | Morning Read: Brexit win throws drug regulation, VC investment in UK life sciences into question | “Key questions about the regulation of medicine, access to the single market and talent, intellectual property and the precise nature of the future relationship of the UK with Europe are now upon us.”
Sarah Hanson, Head of UK Lifesciences a... |
| Jun 16, 2016 | VC hits a high for U.K. biotech, but 'dark spots' remain | Although not as traditionally as strong as the U.S. market, the U.K. venture capital funding rounds for biotechs hit record levels last year as $489 million ($692million) was raised.
This is according to a new report, compiled by the U.K. b... |
| Mar 23, 2016 | Industry taskforce launched to secure future of manufacturing advanced therapy medicines | Industry taskforce launched to secure future of manufacturing advanced therapy medicines
23-03-2016
A new Advanced Therapy Manufacturing Taskforce has been launched by the Medicines Manufacturing Industry Partnership (MMIP) to secure the fu... |
| Apr 30, 2015 | BIA outlines 10-year plan to make U.K. a rival to Boston and the Bay | The UK BioIndustry Association (BIA) has laid out its strategy for turning the United Kingdom into a biotech cluster to rival those in California and Massachusetts. And while the plan has many components, a comparison of the three regions t... |
| Oct 9, 2014 | United Life Sciences to advance UK bioscience and publish UK Life Sciences Manifesto | United Life Sciences to advance UK bioscience and publish UK Life Sciences Manifesto
09-10-2014
Four leading life science membership organisations, the BioIndustry Association (BIA), Bionow, BioPartner and One Nucleus (ON) announce the form... |
| Feb 1, 2013 | Altacor chairman Andy Richards receives BIA lifetime achievement award | Altacor chairman Andy Richards receives BIA lifetime achievement award
01-02-2013
Serial life sciences entrepreneur Dr Andy Richards received the BioIndustry Association (BIA) Lifetime Achievement Award at the Association’s annual Gala Dinn... |
| Jul 26, 2012 | Coaching not quotas is key to achieving boardroom balance in UK Life Sciences | Hatfield, 26 July 2012: Achieving boardroom gender balance is vital to building successful Life Sciences companies – but the industry must do more to make this a reality, according to a major new report published today by RSA, the leading g... |
| Feb 8, 2010 | Industry Leaders Join Forces to Launch the New Voice of UK Life Sciences | Live Webcast: 24th February, 12 noon
Register at MedilinkUK.com
A new website, billed as ‘THE Voice of UK Life Sciences’, will launch on 24th February with a high profile webcast featuring some of the sector’s most respected individuals in ... |
| Nov 18, 2003 | New strategy to make bioscience sector a world beater | New strategy to make bioscience sector a world beater
18-11-2003
A funding package worth 10m to help NHS patients reap the benefits of the latest advances in medical science was announced by the Prime Minister yesterday (Monday).
The invest... |
| Morning Read: Brexit win throws drug regulation, VC investment in UK life sciences into question | A European Union flag, with a hole cut in the middle, flies at half-mast
TOP STORIES
The majority of UK voters supported an exit from the EU, raising a litany of questions for the life sciences industry in the UK. The BioIndustry Associatio... |
| Despite Brexit anxiety, VC investment in UK biotech surges by more than $60M | Despite the UK’s withdrawal from the European Union throwing the country’s politics into chaos and uncertainty, private investment in its biotech industry represents a rare bright spot, according to a new report.
The report, released on Mon... |
| UK life sciences industry grapples with new questions from Brexit spanning funding, regulatory landscape | Last week, Great Britain voted to leave the European Union of 28 member states, or “Brexit.” Since the result was announced sterling has fallen to a 31-year low, there has been a record daily drop in global equity markets and political turm... |
| UK biotech boom: 65% growth in UK biotechnology research and development companies since 2016 as sector attracts record investment | The number of active UK biotechnology businesses in the field of research and experimental development has soared by 65% in just over three years as the sector attracts record levels of funding, according to new analysis by investment manag... |
